Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer

Showing 15 posts of 262 posts found.

Bayer image

Bayer enters $252 million Dimension deal

June 24, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, dimension, haemophilia, haemophilia a, therapeutics

Bayer HealthCare will pay up to $252 million to Dimension Therapeutics in a deal which sees the companies collaborate on …

News
Dieter Weinand image

Bayer announces more changes at the top

June 6, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Dieter Weinand, Otsuka, dekkers, healthcare

US-based president at Japanese drugmaker Otsuka, Dieter Weinand, is to join Bayer Healthcare Pharmaceuticals as the new head of its …

News
Marijn Dekkers, Bayer chief executive

Bayer’s chief executive to step down in 2016

June 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Germany, Marijn Dekkers

Marijn Dekkers the chief executive of German pharma firm Bayer has set his departure date to the end of 2016. …

News

Bayer concludes $14bn Merck consumer care takeover

May 7, 2014
Sales and Marketing Bayer, Merck, OTC, consumer care, merger

 Bayer has confirmed its acquisition of US firm Merck’s over-the-counter (OTC) portfolio in a deal worth $14 billion. The arrangement …

News
Bayer image

Bayer to make $14 bn move for Merck unit

May 2, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Merck, Novartis, Reckitt Benckiser, claritin, reuters

Bayer is in talks with Merck & Co to buy its consumer business and is willing to pay $14 billion …

News
xofigo_bayer

NICE says ‘no’ to Xofigo

March 24, 2014
Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo

NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …

News
Baye image

Xarelto lift for Bayer

March 3, 2014
Manufacturing and Production, Sales and Marketing Bayer, Eylea, Stivarga, Xarelto, blood thinner, xofigo

Bayer Group says sales of its blood thinner Xarelto will be higher than it had predicted, with peak annual sales …

News
Xarelto, bayer, ACS, janssen, fda, asa, blood

Bayer ‘disappointed’ with FDA

February 18, 2014
Sales and Marketing ACS, Bayer, Xarelto, blood, rivaroxaban

Bayer HealthCare has expressed its dismay after the Food and Drug Administration once again rejected further indications for the company’s …

News
Bayer image

Bayer and Regeneron to co-develop wet AMD antibody

January 14, 2014
Research and Development, Sales and Marketing Bayer, Eylea, Regeneron, pdgfr-beta, wet AMD

Bayer and Regeneron are co-developing an antibody to the Platelet Derived Growth Factor Receptor Beta (PDGFR-beta) as a combination therapy …

News
screen_shot_2013-12-23_at_08

Board changes at Bayer

December 23, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, malik

Bayer has appointed Kemal Malik to its management board with responsibility for innovation, succeeding Wolfgang Plischke who is retiring. Bayer …

Appointment
Bayer image

Bayer in $2.9 billion Algeta deal

December 19, 2013
Sales and Marketing Algeta, Bayer, oncology, xofigo

Bayer and Algeta have decided to avoid the usual M&A dance, opting instead to agree a business deal with little …

News

Bayer targets Norway’s Algeta

November 27, 2013
Sales and Marketing Algeta, Bayer, oncology, xofigo

Bayer HealthCare is in the market to buy Norwegian oncology specialist Algeta. The German pharma group has made a bid …

News
nexavar image

US regulator shows Nexavar green light

November 25, 2013
Sales and Marketing Bayer, Cancer, FDA, Nexavar, Onyx, thyroid

The FDA has extended the indication of liver and kidney cancer pill Nexavar to treat late-stage differentiated thyroid cancer. It …

News
Xofigo

Bayer cancer drug gets EU approval

November 18, 2013
Sales and Marketing Bayer, CHMP, EU, Xtandi, Zytiga, xofigo

Bayer’s prostate cancer treatment Xofigo has been shown the green light by the European Commission.  Xofigo (radium Ra 223 dichloride) …

News
Eylea image

Bayer submits Eylea in EU for DME

November 8, 2013
Sales and Marketing Bayer, DME, EMA, Eylea, FDA

Bayer HealthCare is seeking to extend the licence of its VEGF Trap-Eye, which is already marketed as Eylea in various …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025